Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Breyer

Showing results (21-30 of 127) with videos related to

Pageof 13
Sort By:
The Journal of Investigative Dermatology|April 26, 2003
Inflammatory modulation and wound repairJeffrey M Davidson, Matthew D Breyer
Annual Review of Physiology|November 9, 2007
Physiological regulation of prostaglandins in the kidneyChuan-Ming Hao, Matthew D Breyer
Seminars in Nephrology|May 30, 2007
Roles of lipid mediators in kidney injuryChuan-Ming Hao, Matthew D Breyer
Current Opinion in Nephrology and Hypertension|April 13, 2006
Diabetic nephropathy: leveraging mouse geneticsMatthew D Breyer, Zhonghua Qi, Elena Tchekneva
Drug News & Perspectives|April 5, 2003
The Role of PPARs in the Transcriptional Control of Cellular ProcessesYoufei Guan, Yahua Zhang, Matthew D. Breyer
The Journal of Biological Chemistry|November 11, 2003
Hypertonic stress activates glycogen synthase kinase 3beta-mediated apoptosis of renal medullary interstitial cells, suppressing an NFkappaB-driven cyclooxygenase-2-dependent survival pathwayReena Rao, Chuan-Ming Hao, Matthew D Breyer
Disease Models & Mechanisms|October 7, 2015
From bench to patient: model systems in drug discoveryMatthew D Breyer, A Thomas Look, Alessandra Cifra
American Journal of Physiology. Renal Physiology|August 9, 2002
Contribution of prostaglandin EP(2) receptors to renal microvascular reactivity in miceJohn D Imig, Matthew D Breyer, Richard M Breyer
Current Opinion in Investigational Drugs (London, England : 2000)|February 5, 2004
Prostanoid receptors and the urogenital tractMatthew D Breyer, Richard L Hébert, Richard M Breyer
Hypertension (Dallas, Tex. : 1979)|June 28, 2006
Differentiation of cyclooxygenase 1- and 2-derived prostanoids in mouse kidney and aortaZhonghua Qi, Hui Cai, Jason D Morrow, et al.
Pageof 13

Showing results (21-30 of 127) with videos related to

Sort By:
Pageof 13
The Journal of Investigative Dermatology|April 26, 2003
Inflammatory modulation and wound repairJeffrey M Davidson, Matthew D Breyer
Annual Review of Physiology|November 9, 2007
Physiological regulation of prostaglandins in the kidneyChuan-Ming Hao, Matthew D Breyer
Seminars in Nephrology|May 30, 2007
Roles of lipid mediators in kidney injuryChuan-Ming Hao, Matthew D Breyer
Current Opinion in Nephrology and Hypertension|April 13, 2006
Diabetic nephropathy: leveraging mouse geneticsMatthew D Breyer, Zhonghua Qi, Elena Tchekneva
Drug News & Perspectives|April 5, 2003
The Role of PPARs in the Transcriptional Control of Cellular ProcessesYoufei Guan, Yahua Zhang, Matthew D. Breyer
The Journal of Biological Chemistry|November 11, 2003
Hypertonic stress activates glycogen synthase kinase 3beta-mediated apoptosis of renal medullary interstitial cells, suppressing an NFkappaB-driven cyclooxygenase-2-dependent survival pathwayReena Rao, Chuan-Ming Hao, Matthew D Breyer
Disease Models & Mechanisms|October 7, 2015
From bench to patient: model systems in drug discoveryMatthew D Breyer, A Thomas Look, Alessandra Cifra
American Journal of Physiology. Renal Physiology|August 9, 2002
Contribution of prostaglandin EP(2) receptors to renal microvascular reactivity in miceJohn D Imig, Matthew D Breyer, Richard M Breyer
Current Opinion in Investigational Drugs (London, England : 2000)|February 5, 2004
Prostanoid receptors and the urogenital tractMatthew D Breyer, Richard L Hébert, Richard M Breyer
Hypertension (Dallas, Tex. : 1979)|June 28, 2006
Differentiation of cyclooxygenase 1- and 2-derived prostanoids in mouse kidney and aortaZhonghua Qi, Hui Cai, Jason D Morrow, et al.
Pageof 13